Information for physicians on the use of Brentuximab Vedotin treatment
Application designed by Takeda Argentina with the purpose of creating a new communication channel with specialists, who, through this tool, will have at their disposal relevant information about Adcetris (Brentuximab Vedotin), as well as the latest news related to the use of the treatment.
This APP will be characterized by providing innovative and attractive content and value-added proposals.
This APP will be characterized by providing innovative and attractive content and value-added proposals.
